Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85alpha

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• Phosphoinositide 3-kinase (PI3K) is a key signaling enzyme activated by the B cell receptor (BCR) and other receptors on B lymphocytes.
• Mice lacking the predominant PI3K regulatory isoform, p85alpha, display B cell defects similar to those with Bruton's tyrosine kinase (Btk) deficiencies.

Purpose of the Study:

• To conduct a detailed analysis of splenic B cell subsets in p85alpha-deficient mice.
• To elucidate the specific role of PI3K-p85alpha in B cell development and differentiation.

Main Methods:

• Analysis of splenic B cell subsets in p85alpha-deficient mice.
• Comparison with Btk-deficient (Xid) mice.
• Assessment of B cell development in mice with combined p85alpha and Btk genetic lesions.
• Investigation of the effects of transgenic Bcl-2 expression in p85alpha-deficient mice.

Main Results:

• p85alpha-deficient mice lack four major B cell subsets: transitional-1, transitional-2, follicular, and marginal zone.
• These defects differ from those in Xid mice, indicating PI3K-p85alpha's distinct role.
• Mice with combined p85alpha and Btk deficiencies show compounded B cell development impairment.
• Transgenic Bcl-2 expression rescued transitional B cells but not marginal zone B cells, and altered follicular B cell phenotype.

Conclusions:

• PI3K-p85alpha plays a critical role in the differentiation of both follicular and marginal zone B cells.
• The function of PI3K-p85alpha in B cell development extends beyond mediating anti-apoptotic signals.